Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Press Release on Mobile Application “Ballegh Lalsoha”

 
Keen to use the technological means to improve the quality of healthcare services provided and develop mechanisms for work processes and health inspection, the Ministry of Public Health launched on 7 February 2018 a new mobile application “Ballegh Lalsoha” that enables all the citizens to submit a complaint regarding any health violation that threatens the public health and harms the citizen’s health.

Only the registered members on the application are allowed to submit complaints. The Ministry is keen to ensure the privacy and confidentiality of the citizens’ information, and these data are kept at a specific level so as to ensure the highest level of safety and confidentiality for users.
The citizen can send the following information regarding the complaint: the place of violation, type and name of the violating foodstuff company or the type of the environmental violation and the cause for complaint, with the possibility of sending photos, videos or even recordings.  
After inspection is carried to ensure the complaint is valid, the Ministry of Public Health takes the appropriate actions and reports to the Municipality on the place of the violation. The Municipality can, in its turn, learn details on the complaints through the application, in an exclusive manner, without knowing the identity of the complainant.
The application shows the geological distribution of violations according to their type, the percentage of violations is determined according to the number of foodstuff companies located in the municipality.
Colors vary as follows:

Complaints less than 10%

Complaints between 10% and 20%

Complaints more than 20%
 
The Ministry of Public Health warns people against the use of this application to submit false complaint or make allegation against someone to tarnish his reputation, harm or defame him, subject to liability.
We call on the Municipalities, our key partner, to activate the inspection processes, according to the applicable laws, in particular the legislative Decree No. 77/118 which gives the Municipalities the authority to conduct health inspection on foodstuff companies and food safety.
 
We invite all the citizens to download “Ballegh Lalsoha” App to become a partner in responsibility.
 
The application can be downloaded for free from the Google Play and App Store through the following link: www.moph.gov.lb/app
 
    ...
    6
ATC Name B/G Ingredients Dosage Form Price
N05AH03 OLANZAMED G Olanzapine - 10mg 10mg Tablet 902,294 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 10mg 10mg Tablet 822,432 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 7.5mg 7.5mg Tablet 822,432 L.L
C10AA05 ORBALIP G Atorvastatin (calcium) - 20mg 20mg Tablet 1,091,712 L.L
C10AA05 ORBALIP G Atorvastatin (calcium) - 40mg 40mg Tablet 1,405,275 L.L
A12AX OSTRONG G Vitamin D3 - 500IU, Calcium hydrogen phosphate - 600mg Tablet 435,149 L.L
A10BB12 ORBIDE G Glimepiride - 1mg 1mg Tablet 207,336 L.L
A10BB12 ORBIDE G Glimepiride - 2mg 2mg Tablet 209,895 L.L
A10BB12 ORBIDE G Glimepiride - 3mg 3mg Tablet 351,959 L.L
A10BB12 ORBIDE G Glimepiride - 4mg 4mg Tablet 357,078 L.L
A10BD02 ORBIZIDE M FORTE G Metformin HCl - 500mg, Gliclazide - 80mg Tablet 771,750 L.L
M05BA04 OREK G Alendronate - 70mg 70mg Tablet, coated 2,404,838 L.L
N06AB03 OXETINE 20 G Fluoxetine (HCl) - 20mg 20mg Tablet, coated 362,837 L.L
A04AA01 ONDANSETRON BIOGARAN G Ondansetron - 8mg 8mg Tablet, coated 1,307,559 L.L
R01BA52 ORADUS P G Pseudoephedrine sulfate - 120mg, Desloratadine - 2.5mg Tablet, extended release 746,153 L.L
R01BA52 ORADUS P G Pseudoephedrine sulfate - 120mg, Desloratadine - 2.5mg Tablet, extended release 255,970 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 20mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,037,446 L.L
A05AA04 OCALIVA B Obeticholic acid - 10mg 10mg Tablet, film coated 224,503,943 L.L
A05AA04 OCALIVA B Obeticholic acid - 5mg 5mg Tablet, film coated 224,503,943 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 25mg Tablet, film coated 1,067,011 L.L
C09DX03 OLMENOR TRIPLE G Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 5mg, Hydrochlorothiazide - 12.5mg Tablet, film coated 1,067,011 L.L
C02KX04 OPSUMIT B Macitentan - 10mg 10mg Tablet, film coated L.L
C10AA05 ORVASTA G Atorvastatin - 10mg 10mg Tablet, film coated 834,526 L.L
J01CA04 OSPAMOX G Amoxicillin (trihydrate) - 750mg 750mg Tablet, film coated 499,372 L.L
J01CA04 OSPAMOX G Amoxicillin (trihydrate) - 1g 1,000mg Tablet, film coated 683,273 L.L
C02KX04 OPSUMIT B Macitentan - 10mg 10mg Tablet, film coated 153,123,395 L.L
C10AA05 ORVASTA G Atorvastatin - 20mg 20mg Tablet, film coated 920,532 L.L
M04AA03 OXUBAT 120 G Febuxostat - 120mg 120mg Tablet, film coated 1,549,002 L.L
M04AA03 OXUBAT 80 G Febuxostat - 80mg 80mg Tablet, film coated 1,549,002 L.L
C10AA05 ORVASTA G Atorvastatin - 40mg 40mg Tablet, film coated 1,170,487 L.L
    ...
    6
Sitemap
© Copyrights reserved to Ministry of Public Health 2026